Canlyniadau chwilio am the

Both the Partner Expenses Policy and claim form are now available for you to access from the policies section of the Partner Hub.

Today we have launched a consultation which outlines proposed changes to the Standards of conduct, performance and ethics.

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)

What our standards say on scope of practice

Click here to learn what the duty of candour looks like in practice.

The Fitness to practise annual report highlights key statistics and insights and explains how we protect the public and ensure our registrants meet our standards

Our priority is ensuring that registrants have access to advice and support, so that they can get the help they need and ensure they are able to continue to practise safely, without fear of the impact on their registration. To support this, we have produced online materials aimed at registrants and updated our guidance on health and character to include more illustrative case studies.

This webinar will explore the benefits regular reflection can have on your practice and share examples of some of the ways you can achieve reflective practice.

We are seeking views from all our stakeholders on this draft vision, and the other key components which make up our draft corporate strategy

Learn how to overcome the challenges of being open and honest in practice.

The Professional Standards Authority (PSA) has today published its annual performance review of the HCPC. The HCPC has met 16 of the 18 Standards of Good Regulation